Eden Research (LON:EDEN) Announces Quarterly Earnings Results

Eden Research (LON:EDEN) posted its quarterly earnings data on Wednesday. The company reported GBX (0.36) EPS for the quarter, Digital Look Earnings reports. Eden Research had a negative net margin of 44.31% and a negative return on equity of 15.05%.

Eden Research Stock Performance

Eden Research stock traded down GBX 0.03 during midday trading on Thursday, reaching GBX 2.17. The stock had a trading volume of 202,908 shares, compared to its average volume of 585,043. Eden Research has a 12 month low of GBX 1.96 and a 12 month high of GBX 5. The firm’s 50-day moving average price is GBX 2.72 and its 200 day moving average price is GBX 3.16. The firm has a market capitalization of £17.43 million, a PE ratio of -4.90 and a beta of 1.57. The company has a quick ratio of 2.42, a current ratio of 2.25 and a debt-to-equity ratio of 1.43.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides.